Literature DB >> 9084789

Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group.

L Kuhn1, E J Abrams, P B Matheson, P A Thomas, G Lambert, M Bamji, B Greenberg, R W Steketee, D M Thea.   

Abstract

OBJECTIVE: To investigate the hypothesis that labour and delivery events, perinatal characteristics, and maternal factors are only associated with intrapartum HIV transmission, and not with intrauterine HIV transmission.
METHODS: In the New York City Perinatal HIV Transmission Collaborative Study 276 infants of HIV-infected women were followed prospectively and had results of early polymerase chain reaction (PCR) tests available. Among infected children, intrauterine infection was presumed if HIV DNA was detected by PCR in samples collected from children aged < or = 3 days, and intrapartum infection was presumed if HIV DNA was not detected in these early samples. The proportion of infants with presumed intrauterine and intrapartum infections were compared by selected intrapartum, perinatal and maternal characteristics.
RESULTS: Presumed intrapartum infection was found in 7% of infants delivered by Cesarean section and, among infants delivered vaginally, those with longer duration of membrane rupture (> 4 h) were significantly more likely to have presumed intrapartum HIV infection (22%) than those with shorter duration (9%; P = 0.02). There were no differences in presumed intrauterine HIV infection by mode of delivery or longer duration of membrane rupture. Infants born preterm and small for gestational age had significantly higher risks of presumed intrapartum infection, but only those who were small for gestational age had higher risks of intrauterine infection.
CONCLUSION: Our results support the notion that selected intrapartum conditions, long duration of membrane rupture prior to delivery in particular, are independent risk factors for maternal-infant transmission, and suggest that preterm infants may be especially vulnerable to intrapartum HIV exposure.

Entities:  

Mesh:

Year:  1997        PMID: 9084789     DOI: 10.1097/00002030-199704000-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  19 in total

Review 1.  Prevention of perinatal HIV transmission: current status and future developments in anti-retroviral therapy.

Authors:  Athena P Kourtis
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.

Authors:  Dana DeVange Panteleeff; Sandra Emery; Barbra A Richardson; Christine Rousseau; Sarah Benki; Sharon Bodrug; Joan K Kreiss; Julie Overbaugh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 3.  The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.

Authors:  S Maddocks; D Dwyer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  The pharmacological treatment of acute HIV infections in neonates.

Authors:  Louise Kuhn; Stephanie Shiau
Journal:  Expert Rev Clin Pharmacol       Date:  2017-11-03       Impact factor: 5.045

Review 5.  Economic issues in the prevention of vertical transmission of HIV.

Authors:  A E Ades; J Ratcliffe; D M Gibb; M J Sculpher
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

6.  In utero and intra-partum HIV-1 transmission and acute HIV-1 infection during pregnancy: using the BED capture enzyme-immunoassay as a surrogate marker for acute infection.

Authors:  Edmore T Marinda; Lawrence H Moulton; Jean H Humphrey; John W Hargrove; Robert Ntozini; Kuda Mutasa; Jonathan Levin
Journal:  Int J Epidemiol       Date:  2011-04-05       Impact factor: 7.196

7.  Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding.

Authors:  Ivona Pandrea; Richard Onanga; Sandrine Souquiere; Augustin Mouinga-Ondéme; Olivier Bourry; Maria Makuwa; Pierre Rouquet; Guido Silvestri; François Simon; Pierre Roques; Cristian Apetrei
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 8.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

9.  Molecular evidence for mother-to-child transmission of multiple variants by analysis of RNA and DNA sequences of human immunodeficiency virus type 1.

Authors:  C Pasquier; C Cayrou; A Blancher; C Tourne-Petheil; A Berrebi; J Tricoire; J Puel; J Izopet
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.